Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats

European Journal of Pharmacology

Volumn 611, Issue 1-3, 2009, Pages 53-59

  Nagareddy, Prabhakara Reddy ^a   McNeill, John H ^a   MacLeod, Kathleen M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cardiovascular abnormalities; Diabetes; Endothelial dysfunction; Inducible nitric oxide synthase; Nitric oxide

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; HEART; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES; SUPERIOR MESENTERIC ARTERY;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR ABNORMALITIES; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HEART RATE; LYSINE; MALE; MESENTERIC ARTERY, SUPERIOR; METHOXAMINE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; TIME FACTORS; TYROSINE;

EID: 67349222879     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.03.061     Document Type: Article

References (34)

1. Bardell A.L., and MacLeod K.M. Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J. Pharmacol. Exp. Ther. 296 (2001) 252-259
2. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271 (1996) C1424-C1437
3. Bojunga J., Dresar-Mayert B., Usadel K.H., Kusterer K., and Zeuzem S. Antioxidative treatment reverses imbalances of nitric oxide synthase isoform expression and attenuates tissue-cGMP activation in diabetic rats. Biochem. Biophys. Res. Commun. 316 (2004) 771-780
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Ceriello A., Mercuri F., Quagliaro L., Assaloni R., Motz E., Tonutti L., and Taboga C. Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress. Diabetologia 44 (2001) 834-838
6. Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., Berrino L., Rossi F., and Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51 (2002) 1076-1082
7. Ceriello A., Piconi L., Esposito K., and Giugliano D. Telmisartan shows an equivalent effect of vitamin C in further improving endothelial dysfunction after glycemia normalization in type 1 diabetes. Diabetes Care 30 (2007) 1694-1698
8. Cheng X., Cheng X.S., Kuo K.H., and Pang C.C. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes. Cardiovasc. Res. 64 (2004) 298-307
9. Cuzzocrea S., Riley D.P., Caputi A.P., and Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53 (2001) 135-159
10. Ferdinandy P., Danial H., Ambrus I., Rothery R.A., and Schulz R. Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ. Res. 87 (2000) 241-247
11. Frustaci A., Kajstura J., Chimenti C., Jakoniuk I., Leri A., Maseri A., Nadal-Ginard B., and Anversa P. Myocardial cell death in human diabetes. Circ. Res. 87 (2000) 1123-1132
12. Hallinan E.A., Tsymbalov S., Dorn C.R., Pitzele B.S., Hansen Jr. D.W., Moore W.M., Jerome G.M., Connor J.R., Branson L.F., Widomski D.L., Zhang Y., Currie M.G., and Manning P.T. Synthesis and biological characterization of l-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor. J. Med. Chem. 45 (2002) 1686-1689
13. Hebden R.A., Bennett T., and Gardiner S.M. Pressor sensitivities to vasopressin, angiotensin II, or methoxamine in diabetic rats. Am. J. Physiol. 253 (1987) R726-734
14. Heeba G., Hassan M.K., Khalifa M., and Malinski T. Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins. J. Cardiovasc. Pharmacol. 50 (2007) 391-398
15. Hoeldtke R.D. Nitrosative stress in early Type 1 diabetes. David H. P. Streeten Memorial Lecture. Clinic. Auton. Res. 13 (2003) 406-421
16. +, free radicals, and vascular dysfunction in early diabetes mellitus. Diabetologia 40 Suppl 2 (1997) S115-S117
17. Kojda G., Kottenberg K., Nix P., Schluter K.D., Piper H.M., and Noack E. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ. Res. 78 (1996) 91-101
18. Kuzkaya N., Weissmann N., Harrison D.G., and Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J. Biol. Chem. 278 (2003) 22546-22554
19. Lane P., and Gross S.S. Cell signaling by nitric oxide. Semin. Nephrol. 19 (1999) 215-229
20. Martina V., Masha A., Gigliardi V.R., Brocato L., Manzato E., Berchio A., Massarenti P., Settanni F., Della Casa L., Bergamini S., and Iannone A. Long-term N-acetylcysteine and l-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 31 (2008) 940-944
21. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43 (1991) 109-142
22. Nagareddy P.R., Xia Z., McNeill J.H., and MacLeod K.M. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am. J. Physiol. Heart Circ. Physiol. 289 (2005) H2144-H2152
23. Nagareddy P.R., Xia Z., MacLeod K.M., and McNeill J.H. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats. J. Cardiovasc. Pharmacol. 47 (2006) 513-520
24. Nassar T., Kadery B., Lotan C., Da'as N., Kleinman Y., and Haj-Yehia A. Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 436 (2002) 111-118
25. Parrillo J.E. Pathogenetic mechanisms of septic shock. N. Engl. J. Med. 328 (1993) 1471-1477
26. Shesely E.G., Maeda N., Kim H.S., Desai K.M., Krege J.H., Laubach V.E., Sherman P.A., Sessa W.C., and Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13176-13181
27. Smith J.M., Paulson D.J., and Romano F.D. Inhibition of nitric oxide synthase by l-NAME improves ventricular performance in streptozotocin-diabetic rats. J. Mol. Cell. Cardiol. 29 (1997) 2393-2402
28. Soliman H., Craig G.P., Nagareddy P., Yuen V.G., Lin G., Kumar U., McNeill J.H., and Macleod K.M. Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats. Cardiovasc. Res. 79 (2008) 322-330
29. Takakura K., Taniguchi T., Muramatsu I., Takeuchi K., and Fukuda S. Modification of alpha1-adrenoceptors by peroxynitrite as a possible mechanism of systemic hypotension in sepsis. Crit. Care Med. 30 (2002) 894-899
30. Takakura K., Xiaohong W., Takeuchi K., Yasuda Y., and Fukuda S. Deactivation of norepinephrine by peroxynitrite as a new pathogenesis in the hypotension of septic shock. Anesthesiology 98 (2003) 928-934
31. Tyther R., Ahmeda A., Johns E., and Sheehan D. Proteomic identification of tyrosine nitration targets in kidney of spontaneously hypertensive rats. Proteomics 7 (2007) 4555-4564
32. Williamson J.R., Chang K., Frangos M., Hasan K.S., Ido Y., Kawamura T., Nyengaard J.R., van den Enden M., Kilo C., and Tilton R.G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42 (1993) 801-813
33. Xia Z., Kuo K.H., Nagareddy P.R., Wang F., Guo Z., Guo T., Jiang J., and McNeill J.H. N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats. Cardiovasc. Res. 73 (2007) 770-782
34. Zou M.H., Cohen R., and Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium 11 (2004) 89-97